HOOKIPA Pharma Inc. Email Format

Biotechnology ResearchNew York, United States11-50 Employees

HOOKIPA Pharma Inc. is a clinical-stage biotechnology company based in New York, New York, focused on developing immunotherapies that aim to mobilize and amplify targeted T cell responses against cancer and infectious diseases. Its wholly owned pipeline centers on arenavirus-based immunotherapies targeting HPV16+ cancers, prostate cancer, KRAS-mutated cancers (including colorectal, pancreatic, and lung), and other undisclosed programs. The company also collaborates with Gilead to pursue functional cures for hepatitis B virus and HIV. 

Operating in the biotechnology research sector, HOOKIPA positions itself around immunotherapy as a means to address challenging diseases. Its target patient populations include individuals with the specified cancers and with HBV or HIV infections, reflecting a focus on unmet clinical needs through its arenavirus-based approach. In March 2026, HOOKIPA announced the completion of the sale of oncology assets to NeoTrail Therapeutics.

Get verified HOOKIPA Pharma Inc. emails free

Company overview Employee directory